EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
Two men walking on arrows

Sanofi to acquire Blueprint in $9.1bn deal

Sanofi is set to acquire Blueprint Medicines, a US-based biopharmaceutical company specialising in systemic mastocytosis.

King’s Fund sheds light on access to medicine in UK

The King’s Fund in the UK has released an updated explainer on the availability of new medicines in the UK’s NHS.

Kyron.bio lands €5.5m to refine biologic drug design

The Paris biotech aims to improve biologic drugs by mastering glycan control, aiming for safer, more effective therapies.
The word spotlight on a blue background

Spotlight: May 2025

Catch up on May’s key pharma news, research updates and policy shifts.
British government buildings

BioNTech commits £1bn to UK in landmark life sciences investment

BioNTech is set to invest up to £1bn in the UK over the next decade, establishing new R&D and AI hubs.

West Nile Virus found in UK mosquitoes for first time

Experts have pointed to the climate crisis as a potential trigger of the West Nile Virus finding.
The world

WHO chief reveals action on pandemics, climate and AMR

Dr Tedros sets out WHO’s next steps on pandemic preparedness, climate action and AMR during the 78th World Health Assembly in Geneva.

Colorectal cancer leads in real-world data, says Phesi

Colorectal cancer now has the most real-world data, but Phesi warns clinical trials are lagging behind.
We’ve noticed you’re accessing
from North/South America.